For research use only
| Cat No. | ABC-TC3554 |
| Product Type | Hepatic Cells |
| Cell Type | Liver Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human CD34+ Liver Cells support hepatic progenitor studies, liver regeneration research, and stem cell-based modeling of hepatic lineage development.
Human CD34+ Liver Cells are isolated from enzymatically dissociated whole human liver tissue. Following primary culture, the cells are cryopreserved. CD34⁺ liver cells are considered hepatic progenitor or endothelial precursor-like cells. CD34+ Liver Cells are widely used in liver regeneration studies, particularly to investigate their ability to repopulate damaged liver tissue and restore hepatic function. They also serve as a valuable model for exploring mechanisms that regulate the differentiation of CD34+ cells into hepatocytes, with promising implications for cell-based therapies. These cells support research in developmental biology, regenerative medicine, and liver disease modeling. To maintain optimal viability and performance, repeated freeze-thaw cycles should be avoided during handling and culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human CD34+ Liver Cells, CD34 Positive Hepatic Cells, Human Liver CD34+ Progenitors, Hepatic CD34+ Cells, CD34+ Liver Stem Cells |
| Species | Human |
| Cat.No | ABC-TC3554 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Liver Cell |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Hepatic Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human CD34+ Liver Cells can be used as an in vitro cell model to study hepatic progenitor activity, liver tissue regeneration, and endothelial transdifferentiation. These cells are especially valuable in exploring how CD34+ cells differentiate into hepatocyte-like cells under specific conditions. By investigating their plasticity and signaling behavior, researchers can gain deeper insights into potential liver disease treatments and regenerative strategies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).